bibliographicCitation |
Handy WF, Schmidt KT, Price DK, Figg WD. Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADT. Cancer Biology & Therapy. 2020 Aug 13;21(9):782–4. doi: 10.1080/15384047.2020.1796195. |